Skip to main content
Retour
AVBP logo

ArriVent BioPharma, Inc. Common Stock

Qualité des données : 100%
AVBP
NASDAQ Healthcare Biotechnology
22,18 €
▲ 0,16 € (0,73%)
Cap. Boursière : 980,39M
Fourchette du Jour
21,73 € 22,72 €
Fourchette 52 Semaines
15,47 € 27,22 €
Volume
483 405
Moyenne 50J / 200J
22,89 € / 21,19 €
Clôture Précédente
22,02 €

Historique des Prix

Tendances Financières

Comparaison Sectorielle

vs médiane du secteur Healthcare (626 pairs)

Métrique Action Médiane du Secteur
P/E -5,9 0,4
P/B 3,2 2,9
ROE % -58,9 3,8
Net Margin % 3,9
Rev Growth 5Y % 10,0
D/E 0,0 0,2

Points Clés

Debt/Equity of 0,00 — conservative balance sheet
Negative free cash flow of -160,59M

Croissance

Revenue Growth (5Y)
N/A
Revenue (1Y)N/A
Earnings (1Y)N/A
FCF Growth (3Y)N/A

Qualité

Return on Equity
-58,88%
ROIC-43,34%
Net MarginN/A
Op. MarginN/A

Sécurité

Debt / Equity
0,00
Current Ratio12,83
Interest Coverage0,00

Valorisation

P/E Ratio
-5,90
P/B Ratio3,19
EV/EBITDAN/A
Dividend Yield0,00%

All Fundamental Metrics

Growth
Revenue Growth (1Y) N/A Revenue Growth (3Y) N/A
Earnings Growth (1Y) N/A Earnings Growth (3Y) N/A
Revenue Growth (5Y) N/A Earnings Growth (5Y) N/A
Profitability
Revenue (TTM) 0,0 Net Income (TTM) -166,31M
ROE -58,88% ROA -49,92%
Gross Margin N/A Operating Margin N/A
Net Margin N/A Free Cash Flow (TTM) -160,59M
ROIC -43,34% FCF Growth (3Y) N/A
Safety
Debt / Equity 0,00 Current Ratio 12,83
Interest Coverage 0,00 Dividend Yield 0,00%
Valuation
P/E Ratio -5,90 P/B Ratio 3,19
P/S Ratio N/A PEG Ratio -0,07
EV/EBITDA N/A Dividend Yield 0,00%
Market Cap 980,39M Enterprise Value 934,87M

Income Statement

Annual, most recent first

Income statement data, annual, most recent first
Metric FY2025 FY2024 FY2023 FY2022 FY2021
Revenue 0,0 0,0 0,0 0,0 0,0
Net Income -166,31M -80,49M -69,33M -36,91M -51,61M
EPS (Diluted) -4,32 -2,56 -2,17 -1,10 -40,44
Gross Profit 0,0 0,0 0,0 0,0 0,0
Operating Income -177,53M -94,31M -74,59M -36,91M -8,70M

Balance Sheet

Annual, most recent first

Balance sheet data, annual, most recent first
Metric FY2025 FY2024 FY2023 FY2022 FY2021
Total Assets 333,17M 274,94M 163,10M 182,83M 43,04M
Total Liabilities 25,95M 17,29M 11,80M 8,37M 1,82M
Shareholders' Equity 307,22M 257,65M 151,30M 174,46M 41,22M
Total Debt 14 000,0 176 000,0 317 000,0 139 000,0 0,0
Cash & Equivalents 45,54M 74,29M 150,39M 163,37M 37,28M
Current Assets 332,90M 226,98M 159,97M 182,62M 42,95M
Current Liabilities 25,95M 17,27M 11,62M 8,36M 1,82M